- Direction
- Inflecting
- Own history
- —
- Peers
- 73th
- Persistence
- REVERSING
· Electromedical & Electrotherapeutic Apparatus
RESEARCH SNAPSHOTAxogen, Inc.'s latest supported as-filed period reports revenue of $75.8M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 1.84% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 21.81% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 26.22% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 64.70% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 74.81% · CORE
Level · gp.fundamentals.operating_margin
Raw value 1.26% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Shares outstanding increased 29.5%; SBC / revenue moved 257 bp higher.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents changed across a low base; Operating cash flow increased 413.1%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Shares outstanding increased 16.8%; SBC / revenue moved 345 bp higher.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 23.1%; Operating margin moved 604 bp lower; Operating income changed across a sign change.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Gross margin moved 148 bp lower; Operating margin moved 604 bp lower.
2 evidence-backed componentsCash & equivalents changed +372.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
AXGN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0000805928-26-000108SEC ↗8-KOct 28, 2026Period Oct 28, 20260000805928-26-000106SEC ↗8-KOct 1, 2026Period Oct 1, 20260000805928-26-000104SEC ↗8-K/ASep 10, 2026Period Sep 9, 20260001628280-26-061393SEC ↗8-KSep 10, 2026Period Sep 9, 20260001628280-26-061208SEC ↗4Sep 4, 2026Period Sep 2, 20260000805928-26-000101SEC ↗4Aug 12, 2026Period Aug 10, 20260000805928-26-000099SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 2, 2026Filed Sep 4, 2026 | TYNDALL JOSEPH A.Director | Open Market SaleDirect | 3,500 | $50 | $173,940 | Form 4 ↗ |
| Aug 10, 2026Filed Aug 12, 2026 | Began Marc AEVP & General Counsel | Option ExerciseDirect | 67,500 | $8 | $550,800 | Form 4 ↗ |
| Aug 10, 2026Filed Aug 12, 2026 | Began Marc AEVP & General Counsel | Open Market SaleDirect | 67,500 | $47 | $3.2M | Form 4 ↗ |
| Aug 10, 2026Filed Aug 12, 2026 | Began Marc AEVP & General Counsel | Option ExerciseDirect | 67,500 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 11.80% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 11.60% · OPTIONAL
Current assets changed +282.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +154.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +48.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +364.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +29.5% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Noncurrent long-term debt changed -100.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0000805928-26-000098